Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader
98 Pages Posted: 1 Jul 2019 Sneak Peek Status: PublishedMore...
Protein degradation via the use of bivalent chemical degraders provides an alternative strategy to block protein function and assess the biological roles of putative drug targets. This approach capitalizes on the advantages of small molecule inhibitors while moving beyond the restrictions of traditional pharmacology. Herein we report a first-in-class chemical degrader (UNC6852) that targets Polycomb Repressive Complex 2 (PRC2). UNC6852 contains an EED226 derived ligand and a ligand for VHL which bind to the WD40 aromatic cage of EED and CRL2VHL, respectively, to induce proteasomal degradation of PRC2 components, EED, EZH2, and SUZ12. Degradation of PRC2 with UNC6852 blocks the histone methyltransferase activity of EZH2, decreasing H3K27me3 levels in HeLa cells and diffuse large B-cell lymphoma (DLBCL) cells containing an EZH2Y641N gain-of-function mutation. UNC6852 degrades both wild type EZH2 and EZH2Y641N, and additionally displays anti-proliferative effects in this cancer model system.
Keywords: Embryonic Ectoderm Development (EED), Enhancer of Zeste Homolog 2 (EZH2), Suppressor of Zeste Homolog 12 (SUZ12), Polycomb Repressive Complex 2 (PRC2), bivalent chemical degrader, von-Hippel Lindau (VHL), diffuse large B-cell lymphoma (DLBCL), histone methyltransferase (HMT)
Suggested Citation: Suggested Citation